Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1688)	11/13/1998 3:25:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

Rudy, what non-piece-of-crap company would have synergy with CIST and be interested in being acquired or a merger? Thanks for the serious response to my message.

To: Rudy Saucillo who wrote (1688)	11/13/1998 8:30:00 PM
From: John Metcalf	Read Replies (2) \| Respond to of 2742

Geze, Rudy, you answered your own objection-:) >looking at every piece of crap company that makes the news and ask if it's a fit with Cistron< I think that's the fit that Walter saw-:) With its corporate headcount in the single digits, CIST doesn't have the capability to manage another company with which it might merge. As I see it, Cistron can: 1) make a success of its business by further licensing its patents. 2) sell the company 3) liquidate the company. As long as they work on becoming a success, they'll be paying a CEO. For those who don't think this alternative is worthwhile, please realistically consider the other alternatives. Such consideration answers the question of who wants Grausz' shares: investors might want his voting clout to push for sale/liquidation. Having filed bankruptcy, Grausz is probably restricted from disposing his shares, but should still be able to vote them. As to being profitable on earnings from cash-and-equivalents, the company could be more so if they liquidated and had a bank trust department invest the money and send shareholders a dividend on earnings. This would require no employees, equipment, nor premises. My preference would not be to do so, but to simply send a liquidation dividend, following disposal of the patent rights and other assets.